We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleS&P/ASX 200 rose 1% in June with large caps leading gains with mid, small and emerging companie...
Read ArticleASX down 0.5pc, Energy sector up due mainly to Woodside’s upgrade. CRH to acquire Adbri, ending Adb...
Read ArticleAussie shares rise in arvo trade Resources sectors weigh, Real Estate adds 2pc GDP lowest in 40 yea...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleTech stocks surged on ASX today, offset by losses in Mining stocks Gold and copper hit all-time hig...
Read ArticleASX 200’s rally was driven mainly by gold/silver and iron ore stocks Gold prices hit record high as...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleThe ASX200 closed +0.5% higher on Tuesday on the back of a big lift in the Mining sector. Lithium s...
Read ArticleThe ASX 200 traded sideways on Tuesday, closing the day flattish as gains in healthcare stocks were...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleThe ASX 200 had another fine day, ending with a 0.73% gain overall Sectors wise, Tech and Real Esta...
Read ArticleS&P/ASX 200 closes up 1% – its best performance in about a week All sectors bar IT and Utiliti...
Read ArticleFor the first day of the trading week the market rallied, gaining one per cent. The boost came af...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleAussie markets expended a lot of energy to go precisely nowhere Guatam Adani left with less than US...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleLittle joy for investors in December with traditional Christmas rally not eventuating in 2022 Meteo...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleDrug discovery and development company Vectus Biosystems (ASX: VBS) has launched a $4.5 million capi...
Read ArticleASX 200 ends 0.7% higher Small cap index flat NYM, BEZ, CPH best in show Lithium keeps finding...
Read ArticleWelcome to the end of the start of the week. We trust you’ve all had a restful weekend, full of what...
Read ArticleFibrotic diseases specialist Vectus Biosystems (ASX: VBS) has confirmed that it will move to the nex...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleEmerging gold miner Tietto Minerals has a new Chinese Mining giant as a substantial shareholder Env...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleAs with almost every other drug developer on the planet, Vectus Biostsyems (ASX:VBS) co-founder Maur...
Read ArticleASX 200 jumps on blue cap strength Small caps skulk around parity New Hope Coal: So. Much. New. Hop...
Read ArticleBiotechnology company Vectus Biosystems (ASX: VBS) has announced the completion of its phase 1a stud...
Read ArticleBiotron commences human trial of COVID-19 Pancreatic trial news from Noxopharm and Clarity Pharma V...
Read ArticleAhead of enticing pharmaceutical partners, Vectus Biosystems (ASX: VBS) is confident that positive r...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleBenchmark down 1.6%, small caps 2% Shares dive on surprise size of rate hike Dateline Resources li...
Read ArticleVectus announced promising Phase 1 study results Emyria’s CBD capsule demonstrates bioavailability...
Read ArticleThe S&P/ASX 200 Health Care Index (ASX: XHJ) is in the red today, but one ASX biotech share is...
Read ArticlePeter Switzer talks with Vectus Biosystems (VBS) CEO, Maurie Stang.
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleIt’s been an emotional ride for fans of the ASX200 (XJO) which, alongside the Emerging Companies (XE...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleTrading Places is Stockhead’s semi-regular, pretty damn fascinating recap of the latest red flag buy...
Read ArticleAt the time of writing, the ASX 200 Health Index (XHJ) is down by 1.90%, while the benchmark ASX 200...
Read ArticleWall Street down ahead of long weekend Queen Elizabeth has reportedly tested positive for COVID-19,...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleJust like yesterday the ASX rallied for most of the day but retreated in the afternoon and today clo...
Read ArticleAfter treading water since the start of September, the ASX 200 took a dive in Thursday trade to fini...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIDT Australia (ASX:IDT) jumped more than 20% after announcing that it has formalised activities with...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleFertoz Ltd (ASX:FTZ) topped the pops with a red hot 14-day RSI of 93 after two massive days to finis...
Read ArticleSummary The S&P/ASX200 closes Thursday session a tad bit lower, dropped 0.37%. eCargo posts...
Read ArticleSummary The ASX 200 ends 27.20 points or 0.37% lower at 7,359. Seven out of 11 sectors ended in...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleWall Street down as Fed signals two rates rises by 2023 All major indices in the US fell on Thursday...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleA quick wrap of the ASX’s key winners and losers on Thursday, August 27. Data is taken after the mar...
Read ArticleA quick wrap of the key winners and losers on Wednesday, May 20. Data is taken after the market clos...
Read ArticleNow may not be the time to tell investors you’re about to start selling cosmetics to China, but ASX...
Read ArticleOn Stockhead today, the major oilies want to help Australia build a big hydrogen industry, the priva...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
